查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
智慧體外診斷市場：體外診斷人工智慧 - 依應用、技術和使用者預測 - 附執行顧問指南（2024-2028）
市場調查報告書
商品編碼
1472606

智慧體外診斷市場：體外診斷人工智慧 - 依應用、技術和使用者預測 - 附執行顧問指南（2024-2028）

Smart In Vitro Diagnostics. Artificial Intelligence for IVD Markets by Application, By Technology, and By User. With Executive and Consultant Guides 2024-2028
出版日期: | 出版商: Howe Sound Research | 英文 540 Pages | 商品交期: 最快1-2個工作天內

價格

智慧體外診斷市場正從研究模式轉向臨床模式。隨著醫生利用所有可用資訊來對抗疾病，該市場正在爆炸性擴張。同時，製藥公司看到了幾乎所有治療方法都變得可行的潛力。

該報告考察了全球智慧體外診斷市場，並提供了市場概述、應用、技術和用戶的趨勢以及參與市場的公司概況。

目錄

第一章 市場引導

第二章介紹和市場定義

  • 什麼是智能體外診斷？
  • 市場定義
  • 調查方法
  • 觀點：醫療保健和IVD產業

第 3 章市場概況

  • 市場進入組織
    • 學術研究所
    • 診斷測試開發人員
    • 儀器儀表供應商
    • 藥品及試劑製造商
    • 病理學供應商
    • 獨立臨床實驗室
    • 國家研究所
    • 醫院實驗室
    • 臨床實驗室
    • 審計機構
    • 認證機構
  • 瞭解人工智慧
  • 人工智慧在IVD的應用

第四章 市場趨勢

  • 增長動力
  • 生長抑制因素
  • 測量、自動化和診斷的趨勢

第五章 近期趨勢

第六章 主要公司簡介

  • Adaptive Biotechnologies
  • Aidoc
  • Anumana
  • ARUP Laboratories
  • Atomwise
  • Bayesian Health
  • Behold.ai
  • BGI Genomics Co. Ltd
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • Cambridge Cognition
  • Cardiologs（Phillips）
  • CareDx
  • Caris Molecular Diagnostics
  • Cleerly
  • ClosedLoop AI
  • CloudMedX Health
  • Deepcell
  • Digital Diagnostics
  • EKF Diagnostics Holdings
  • Freenome
  • GE Healthcare
  • Glooko
  • Idoven
  • Illumina
  • Infohealth
  • Jade
  • K Health
  • Lunit
  • MaxCyte
  • Mayo Clinic Laboratories
  • Medtronic
  • Merative
  • Nanox
  • NIOX Group
  • Niramai Health Analytix
  • NVIDIA
  • Oncohost
  • OraLiva
  • Owkin
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Paige.AI
  • PathAI
  • Perthera
  • Philips Healthcare
  • Prognos
  • Qiagen
  • Qure.ai
  • Renalytix
  • Seegene
  • Siemens Healthineers
  • Sophia Genetics
  • Sysmex
  • Viz.ai

第七章 全球智慧體外診斷市場

  • 國家：世界市場概況
  • 依應用：全球市場概覽
  • 依技術分類：世界市場概覽
  • 依地區劃分：全球市場概覽

第八章全球智慧體外診斷市場：依應用分類

  • 癌症
  • 傳染病測試
  • 代謝測試
  • 心臟測試
  • 糖尿病測試
  • 其他

第九章全球智慧體外診斷市場：依技術分類

  • NGS
  • PCR
  • 化學/IA
  • 病理
  • 其他

第10章全球智慧體外診斷市場：依地點

  • 研究
  • 藥物研究
  • 臨床
  • 其他

第十一章附錄

OVERVIEW:

Will Smart Diagnostics replace the physician? Will the power of Artificial Intelligence provide better diagnostics? The market is moving out of a research mode into the clinic. The market is exploding as physicians use all the information they can get to battle disease. While Pharmaceutical Companies see the potential to make nearly any therapy viable. Find out how this new approach to diagnostics will change medical care forever.

Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of many diagnostics continues to fall.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of United States Medicare Fee Payment Schedules to help understand the new pricing for nucleic acid based tests. Forecast demand for new testing regimes or technologies. Make research investment decisions. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What are Smart Diagnostics?
  • 2.2. Market Definition
    • 2.2.1. Revenue Market Size
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Understanding Artificial Intelligence
    • 3.2.1. Artificial intelligence
    • 3.2.2. Machine learning
    • 3.2.3. Deep learning
    • 3.2.4. Convolutional neural networks
    • 3.2.5. Generative adversarial networks
    • 3.2.6. Limitations
  • 3.3. AI Applications in IVD
    • 3.3.1. Infectious Disease
      • 3.3.1.1. Known vs. Unknown
      • 3.3.1.2. TMI
      • 3.3.1.3. Disease surveillance
      • 3.3.1.4. Outbreak detection
      • 3.3.1.5. Contact tracing
      • 3.3.1.6. Forecasting
      • 3.3.1.7. Drug discovery
      • 3.3.1.8. Resource allocation
    • 3.3.2. Oncology
      • 3.3.2.1. Electronic health records
      • 3.3.2.2. Genomic analysis
      • 3.3.2.3. Treatment planning
      • 3.3.2.4. Clinical trial matching
    • 3.3.3. Anatomic Pathology
      • 3.3.3.1. Image analysis
      • 3.3.3.2. Tumor segmentation
      • 3.3.3.3. Disease classification
      • 3.3.3.4. Predictive modeling
      • 3.3.3.5. Quality control
      • 3.3.3.6. Digital pathology
    • 3.3.4. Cardiology
      • 3.3.4.1. Electrocardiogram analysis
      • 3.3.4.2. Electronic health records
      • 3.3.4.3. Genomic analysis
      • 3.3.4.4. Treatment planning
      • 3.3.4.5. Prediction of outcomes
    • 3.3.5. Diabetes
      • 3.3.5.1. Diagnosis
      • 3.3.5.2. Blood glucose monitoring
      • 3.3.5.3. Personalized treatment plans
      • 3.3.5.4. Medication management
      • 3.3.5.5. Diabetes education
      • 3.3.5.6. Predictive analytics
    • 3.3.6. General Medicine
      • 3.3.6.1. Diagnosis
      • 3.3.6.2. Predictive Analytics
      • 3.3.6.3. Personalized Treatment Plans
      • 3.3.6.4. Medication Management
      • 3.3.6.5. Disease Monitoring
      • 3.3.6.6. Telemedicine

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Outcome Improvement
    • 4.1.2. The Aging Effect
    • 4.1.3. Cost Containment
    • 4.1.4. Physician Impact
    • 4.1.5. Cost of Intelligence
  • 4.2. Factors Limiting Growth
    • 4.2.1. State of knowledge
    • 4.2.2. Genetic Blizzard
    • 4.2.3. Protocol Resistance
    • 4.2.4. Regulation and coverage
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point Of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. UK to Rollout Digital Pathology Across NHS
  • 5.3. AI Based Next-Generation Colorectal Cancer Test
  • 5.4. Evident, Corista, Sakura Finetek, Visiopharm Form Digital Pathology Alliance
  • 5.5. Viome Life Sciences Raises $86.5M in Oversubscribed Series C Round
  • 5.6. Becton Dickinson Gets Clearance for AI-Based Bacterial Imaging
  • 5.7. Paige, Leica Biosystems Expand Digital Pathology Partnership
  • 5.8. Clarapath Acquires Digital Pathology Company Crosscope
  • 5.9. CanSense to Develop Colorectal Cancer Test
  • 5.10. Owkin-led Machine Learning Study IDs Cancer Treatment Biomarkers
  • 5.11. Guardant Health to Integrate Lunit's AI PD-L1 Algorithm
  • 5.12. Vesale Bioscience to Develop AI Phage Therapy Diagnostic Platform
  • 5.13. Caris Life Sciences To Use AI and Machine Learning
  • 5.14. Numares Health To Develop AI for "Metabolite Constellations"
  • 5.15. Sepsis Testing Startup DeepUll to Use AI for Medical Decisions
  • 5.16. Viome Life Sciences Raises $67M in Series C Financing For AI Cancer Dx
  • 5.17. ADM Diagnostics Wins Grant for Brain Injury Test Development
  • 5.18. Paige to Develop New AI-based Pathology Test
  • 5.19. Aiforia Gains CE-IVD Mark for AI-Powered Histopathology
  • 5.20. Genetic Profiling May Identify Patients Who Do Not Need Radiation Therapy
  • 5.21. Thermo Fisher Introduces Homologous Score for Cancer Profiling
  • 5.22. Genomic Test IDs Cancer Cells Early

6. Profiles of Key Players

  • 6.1. Adaptive Biotechnologies
  • 6.2. Aidoc
  • 6.3. Anumana
  • 6.4. ARUP Laboratories
  • 6.5. Atomwise
  • 6.6. Bayesian Health
  • 6.7. Behold.ai
  • 6.8. BGI Genomics Co. Ltd
  • 6.9. bioMerieux Diagnostics
  • 6.10. Bio-Rad Laboratories, Inc
  • 6.11. Cambridge Cognition
  • 6.12. Cardiologs (Phillips)
  • 6.13. CareDx
  • 6.14. Caris Molecular Diagnostics
  • 6.15. Cleerly
  • 6.16. ClosedLoop AI
  • 6.17. CloudMedX Health
  • 6.18. Deepcell
  • 6.19. Digital Diagnostics
  • 6.20. EKF Diagnostics Holdings
  • 6.21. Freenome
  • 6.22. GE Healthcare
  • 6.23. Glooko
  • 6.24. Idoven
  • 6.25. Illumina
  • 6.26. Infohealth
  • 6.27. Jade
  • 6.28. K Health
  • 6.29. Lunit
  • 6.30. MaxCyte
  • 6.31. Mayo Clinic Laboratories
  • 6.32. Medtronic
  • 6.33. Merative
  • 6.34. Nanox
  • 6.35. NIOX Group
  • 6.36. Niramai Health Analytix
  • 6.37. NVIDIA
  • 6.38. Oncohost
  • 6.39. OraLiva
  • 6.40. Owkin
  • 6.41. Oxford Nanopore Technologies
  • 6.42. Pacific Biosciences
  • 6.43. Paige.AI
  • 6.44. PathAI
  • 6.45. Perthera
  • 6.46. Philips Healthcare
  • 6.47. Prognos
  • 6.48. Qiagen
  • 6.49. Qure.ai
  • 6.50. Renalytix
  • 6.51. Seegene
  • 6.52. Siemens Healthineers
  • 6.53. Sophia Genetics
  • 6.54. Sysmex
  • 6.55. Viz.ai

7. The Global Market for Smart Diagnostics

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table-Global Market by Country
    • 7.1.2. Chart-Global Market by Country
  • 7.2. Global Market by Application-Overview
    • 7.2.1. Table-Global Market by Application
    • 7.2.2. Chart-Global Market by Application-Base/Final Year Comparison
    • 7.2.3. Chart-Global Market by Application-Base Year
    • 7.2.4. Chart-Global Market by Application-Final Year
    • 7.2.5. Chart-Global Market by Application-Share by Year
    • 7.2.6. Chart-Global Market by Application-Segment Growth
  • 7.3. Global Market by Technology-Overview
    • 7.3.1. Table-Global Market by Technology
    • 7.3.2. Chart-Global Market by Technology-Base/Final Year Comparison
    • 7.3.3. Chart-Global Market by Technology-Base Year
    • 7.3.4. Chart-Global Market by Technology-Final Year
    • 7.3.5. Chart-Global Market by Technology-Share by Year
    • 7.3.6. Chart-Global Market by Technology-Segment Growth
  • 7.4. Global Market by Place-Overview
    • 7.4.1. Table-Global Market by Place
    • 7.4.2. Chart-Global Market by Place-Base/Final Year Comparison
    • 7.4.3. Chart-Global Market by Place-Base Year
    • 7.4.4. Chart-Global Market by Place-Final Year
    • 7.4.5. Chart-Global Market by Place-Share by Year
    • 7.4.6. Chart-Global Market by Place-Segment Growth

8. Global Markets-By Application

  • 8.1. Cancer
    • 8.1.1. Table Cancer Testing-by Country
    • 8.1.2. Chart-Cancer Testing Growth
  • 8.2. Infectious Disease Testing
    • 8.2.1. Table Infectious Disease Testing-by Country
    • 8.2.2. Chart-Infectious Disease Testing Growth
  • 8.3. Metabolic Testing
    • 8.3.1. Table Metabolic Testing-by Country
    • 8.3.2. Chart-Metabolic Testing Growth
  • 8.4. Cardiac Testing
    • 8.4.1. Table Cardiac Testing-by Country
    • 8.4.2. Chart-Cardiac Testing Growth
  • 8.5. Diabetes Testing
    • 8.5.1. Table Diabetes Testing-by Country
    • 8.5.2. Chart-Diabetes Testing Growth
  • 8.6. Other Disease Testing
    • 8.6.1. Table Other Disease Testing-by Country
    • 8.6.2. Chart-Other Disease Testing Growth

9. Global Markets-By Technology

  • 9.1. NGS Technology
    • 9.1.1. Table NGS Technology-by Country
    • 9.1.2. Chart-NGS Technology Growth
  • 9.2. PCR Technology
    • 9.2.1. Table PCR Technology-by Country
    • 9.2.2. Chart-PCR Technology Growth
  • 9.3. Chemistry/IA Technology
    • 9.3.1. Table Chemistry/IA Technology-by Country
    • 9.3.2. Chart-Chemistry/IA Technology Growth
  • 9.4. Pathology Technology
    • 9.4.1. Table Pathology Technology-by Country
    • 9.4.2. Chart-Pathology Technology Growth
  • 9.5. Other Technology
    • 9.5.1. Table Other Technology-by Country
    • 9.5.2. Chart-Other Technology Growth

10. Global Markets-By Place

  • 10.1. Research
    • 10.1.1. Table Research-by Country
    • 10.1.2. Chart-Research Growth
  • 10.2. Pharmaceutical Research
    • 10.2.1. Table Pharmaceutical Research-by Country
    • 10.2.2. Chart-Pharmaceutical Research Growth
  • 10.3. Clinical
    • 10.3.1. Table Clinical-by Country
    • 10.3.2. Chart-Clinical Growth
  • 10.4. Other Place
    • 10.4.1. Table Other Place-by Country
    • 10.4.2. Chart-Other Place Growth

11. Appendices

  • 11.1. United States Clinical Laboratory Fees Schedule
    • 11.1.1. Laboratory Fees Schedule
    • 11.1.2. The Most Used IVD Assays
    • 11.1.3. The Highest Grossing Assays

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Factors Driving Growth
  • Table 3: Four Factors Limiting Growth
  • Table 4: Seven Key Diagnostic Laboratory Technology Trends
  • Table 5: Global Market by Region
  • Table 6: Global Market by Application
  • Table 7: Global Market by Technology
  • Table 8: Global Market by Place
  • Table 9: Cancer Testing by Country
  • Table 10: Infectious Disease Testing by Country
  • Table 11: Metabolic Testing by Country
  • Table 12: Cardiac Testing by Country
  • Table 13: Diabetes Testing by Country
  • Table 14: Other Disease Testing by Country
  • Table 15: NGS Technology by Country
  • Table 16: PCR Technology by Country
  • Table 17: Chemistry/IA Technology by Country
  • Table 18: Pathology Technology by Country
  • Table 19: Other Technology by Country
  • Table 20: Research by Country
  • Table 21: Pharmaceutical Research by Country
  • Table 22: Clinical by Country
  • Table 23: Other Place by Country
  • Table 24: Laboratory Fee Schedule
  • Table 25: The Most Common Assays
  • Table 26: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: The Road to Diagnostics
  • Figure 4: AI and Learning Methods
  • Figure 5: The Changing Age of The World's Population
  • Figure 6: Health Care Consumption by Age
  • Figure 7: Cancer Incidence-Age at Diagnosis
  • Figure 8: Centralized vs. Decentralized Laboratory Service
  • Figure 9: A Highly Multiplexed Syndromic Testing Unit
  • Figure 10: The Real Cost to Sequence the Human Genome
  • Figure 11: The Codevelopment Process
  • Figure 12: Comparing MDx Diagnostic and Traditional Testing
  • Figure 13: Base Year Country Global Share
  • Figure 14: Global Market by Application-Base vs. Final Year
  • Figure 15: Market by Application Base Year
  • Figure 16: Market by Application Final Year
  • Figure 17: Application Share by Year
  • Figure 18: Application Segment Growth
  • Figure 19: Global Market by Technology-Base vs. Final Year
  • Figure 20: Market by Technology Base Year
  • Figure 21: Market by Technology Final Year
  • Figure 22: Market by Technology Share by Year
  • Figure 23: Market by Technology Segment Growth
  • Figure 24: Market by Place-Base vs. Final Year
  • Figure 25: Market by Place Base Year
  • Figure 26: Market by Place Final Year
  • Figure 27: Market by Place Share by Year
  • Figure 28: Market by Place Segment Growth
  • Figure 29: Cancer Testing Growth
  • Figure 30: Infectious Disease Testing Growth
  • Figure 31: Metabolic Testing Growth
  • Figure 32: Cardiac Testing Growth
  • Figure 33: Diabetes Testing Growth
  • Figure 34: Other Disease Testing Growth
  • Figure 35: NGS Technology Growth
  • Figure 36: PCR Technology Growth
  • Figure 37: Chemistry/IA Technology Growth
  • Figure 38: Pathology Technology Growth
  • Figure 39: Other Technology Growth
  • Figure 40: Research Growth
  • Figure 41: Pharmaceutical Research Growth
  • Figure 42: Clinical Growth
  • Figure 43: Other Place Growth